1. Home
  2. JCI vs BSX Comparison

JCI vs BSX Comparison

Compare JCI & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Johnson Controls International plc

JCI

Johnson Controls International plc

N/A

Current Price

$135.47

Market Cap

84.0B

Sector

Industrials

ML Signal

N/A

Logo Boston Scientific Corporation

BSX

Boston Scientific Corporation

N/A

Current Price

$70.44

Market Cap

137.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
JCI
BSX
Founded
1885
1979
Country
Ireland
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
84.0B
137.8B
IPO Year
2007
2010

Fundamental Metrics

Financial Performance
Metric
JCI
BSX
Price
$135.47
$70.44
Analyst Decision
Buy
Strong Buy
Analyst Count
14
20
Target Price
$132.54
$109.15
AVG Volume (30 Days)
3.7M
12.8M
Earning Date
05-08-2026
05-06-2026
Dividend Yield
1.21%
N/A
EPS Growth
99.60
55.20
EPS
0.85
1.94
Revenue
$9,902,000,000.00
$9,076,000,000.00
Revenue This Year
$7.66
$12.04
Revenue Next Year
$6.44
$10.48
P/E Ratio
$155.48
$36.74
Revenue Growth
N/A
12.49
52 Week Low
$68.03
$70.75
52 Week High
$146.49
$109.50

Technical Indicators

Market Signals
Indicator
JCI
BSX
Relative Strength Index (RSI) 49.56 31.39
Support Level $111.18 N/A
Resistance Level $146.49 $76.77
Average True Range (ATR) 3.22 1.73
MACD -1.98 0.24
Stochastic Oscillator 29.99 8.23

Price Performance

Historical Comparison
JCI
BSX

About JCI Johnson Controls International plc

Following Johnson Controls' divestiture of its residential and light commercial HVAC businesses to Bosch in 2025, nearly all of its revenue comes from commercial HVAC (60%) and fire and security products and services (40%). A 2016 merger joined Johnson Controls' HVAC and Tyco's fire and security businesses with the premise that there is synergy in offering a broader variety of automation products and solutions to commercial buildings. We estimate Johnson Controls' pro forma revenue mix will be one-third products, one-third installation, and one-third services.

About BSX Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.

Share on Social Networks: